Test Directory
| Test Code | ||||||||||||||||||||||||||||||
| 1735 | ||||||||||||||||||||||||||||||
| Test Name | ||||||||||||||||||||||||||||||
| Cutaneomucosal Venous Malformations | ||||||||||||||||||||||||||||||
| CPT Codes | ||||||||||||||||||||||||||||||
| 81479 | ||||||||||||||||||||||||||||||
| Expected Turnaround Time | ||||||||||||||||||||||||||||||
| Typically 2 to 4 weeks from receipt of a sample in the laboratory. All cases involving ongoing pregnancies will be expedited. | ||||||||||||||||||||||||||||||
| Clinical Utility | ||||||||||||||||||||||||||||||
| Genetic analysis to provide a molecular diagnosis of this disorder. Recommended for individuals with a personal and/or family history of this disorder to ensure appropriate treatment and establish recurrence risk for family members. | ||||||||||||||||||||||||||||||
| Specimen and Container Info | ||||||||||||||||||||||||||||||
|
Non-Prenatal Specimens
Prenatal Specimens Either specimen type below is acceptable.
NOTE: For specimens from outside of North America, the preferred specimen type is Genomic DNA. HNL Genomics does not recommend shipping whole blood or cultured cells from any location other than the United States, Canada, or Mexico. |
||||||||||||||||||||||||||||||
| Transport Instructions | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Stability Requirements | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Causes for Rejection | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Methodology | ||||||||||||||||||||||||||||||
| Next Generation Sequencing and Copy Number Variation Analysis | ||||||||||||||||||||||||||||||
| Performing Location | ||||||||||||||||||||||||||||||
| Genomics - Snowdrift | ||||||||||||||||||||||||||||||
| Alternate Names | ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Description | ||||||||||||||||||||||||||||||
|
Glomuvenous malformations (GVM) and Cutaneomucosal venous malformations (VMCM) - Glomuvenous malformations (GVM; MIM 138000) are a type of vascular malformation mainly involving the skin and subcutis of the extremities. GVM are often present at birth and slowly expand. Typically they are nodular, multifocal hyperkeratotic lesions with a cobble stone appearance. They are often painful on palpation, pink to dark blue in color and cannot be emptied on compression. These features distinguish GVM from typical venous malformation. Histologically, GVM are characterized by distended vascular channels surrounded by mural glomus cells. Glomus cells are considered to be abnormally differentiated vascular smooth muscle cells. GVM are caused by loss of function mutations in the glomulin (GLMN) gene. Although inheritance is considered to be autosomal dominant, some evidence suggests that a 'second hit' somatic mutation (paradominant inheritance) is required for the lesions to develop. Cutaneomucosal venous malformations (VMCM; MIM 600195) are inherited in autosomal dominant manner with incomplete penetrance. VMCM are characterized by small, soft, blue colored, multifocal venous malformations that can be seen at birth. Unlike the GVM, VMCM can be emptied by external pressure. The VMCM can involve skin and oral mucosa. VMCM are caused by mutations in the endothelial cell tyrosine kinase receptor gene (TEK, formerly known as TIE2). |
||||||||||||||||||||||||||||||
| Testing Schedule | ||||||||||||||||||||||||||||||
| Monday-Friday | ||||||||||||||||||||||||||||||
| Genes | ||||||||||||||||||||||||||||||
| TEK | ||||||||||||||||||||||||||||||
| MIM | ||||||||||||||||||||||||||||||
| 600195 | ||||||||||||||||||||||||||||||
| Disease Group | ||||||||||||||||||||||||||||||
| Cardiovascular Disorders, Skin | ||||||||||||||||||||||||||||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.